Women who filed Ethicon vaginal mesh lawsuits moved closer to realizing their days in court this August when Ethicon Inc., a Johnson & Johnson subsidiary, filed its Answer to the First Amended Master Complaint in the federal Ethicon transvaginal mesh multidistrict litigation (“MDL”) underway in the U.S. District Court, Southern District of West Virginia.

In the Answer filed on August 31, 2012, it was revealed that there are several products at the center of the Ethicon vaginal mesh lawsuits, which were filed by plaintiffs who claim to have suffered mesh erosion, urinary problems, chronic pain, scarring and other serious injuries after being implanted with the surgical material.

The company’s Prolene Mesh/Prolene Soft Mesh, TVT Abbrevo, TVT Exact, TVT-SECUR, TVT-Obturator, Gynemesh, Gynemesh PS, Prolift, Prolift + M, and Prosima vaginal mesh devices were all named in the litigation, (In re:Ethicon, Inc., Pelvic Repair System Products Liability Litigation – MDL No. 2327).  

Interestingly, this news comes in the wake of Ethicon’s announcement in June that it would stop selling four of the above pelvic mesh implants. As part of that decision, the manufacturer asked the U.S. Food and Drug Administration (“FDA”) for 120 days to cease commercialization of the Gynecare TVT Secur System, Gynecare Prosima Pelvic Floor Repair System, Gynecare Prolift Pelvic Floor Repair System; and the Gynecare Prolift+M Pelvic Floor System.

Ethicon isn’t the only transvaginal mesh manufacturer preparing to defend itself in federal court, though. American Medical Systems, Boston Scientific Corp, and C.R. Bard Inc. are also involved in large transvaginal mesh litigations pending in courts around the U.S.

Transvaginal mesh has been the subject of mounting controversy in recent years. In October 2008, the FDA issued its first health notification acknowledging the dangers of transvaginal mesh, but classified the instances as ‘rare.’ Then in 2011, the FDA released another alert, but this time cited the potential for side effects stemming from the surgical material as ‘not rare.’ This was after the agency was flooded with more than 2,800 adverse event reports of complication from 2008-2010.

Trial dates for the Ethicon vaginal mesh lawsuits filed in the federal Ethicon transvaginal mesh multidistrict litigation have yet to be scheduled. Check here for the last transvaginal mesh information.

Published October 9, 2012 by